As of 2024-12-11, the Relative Valuation of Oncozenge AB (ONCOZ.ST) is - SEK. This relative valuation is based on P/E multiples. With the latest stock price at 3.87 SEK, the upside of Oncozenge AB based on Relative Valuation is -.
The range of the Relative Valuation is - SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-29 | -4.23 |
| 2024-11-28 | -4.57 |
| 2024-11-27 | -4.13 |
| 2024-11-26 | -3.98 |
| 2024-11-25 | -3.92 |
| 2024-11-22 | -3.47 |
| 2024-11-21 | -4.02 |
| 2024-11-20 | -9.83 |
| 2024-11-19 | -9.84 |
| 2024-11-18 | -10.28 |
| 2024-11-15 | -8.50 |
| 2024-11-14 | -8.28 |
| 2024-11-13 | -8.29 |
| 2024-11-12 | -7.78 |
| 2024-11-11 | -7.89 |
| 2024-11-08 | -8.39 |
| 2024-11-07 | -8.62 |
| 2024-11-06 | -8.84 |
| 2024-11-05 | -9.16 |
| 2024-11-04 | -9.66 |
| 2024-11-01 | -9.74 |
| 2024-10-31 | -9.72 |
| 2024-10-30 | -8.81 |
| 2024-10-29 | -8.38 |
| 2024-10-28 | -9.73 |
| 2024-10-25 | -10.26 |
| 2024-10-24 | -10.56 |
| 2024-10-23 | -11.51 |
| 2024-10-22 | -10.40 |
| 2024-10-21 | -10.04 |
| 2024-10-18 | -9.20 |
| 2024-10-17 | -8.26 |
| 2024-10-16 | -8.13 |
| 2024-10-15 | -8.09 |
| 2024-10-14 | -7.88 |
| 2024-10-11 | -7.89 |
| 2024-10-10 | -7.03 |
| 2024-10-09 | -7.06 |
| 2024-10-08 | -6.94 |
| 2024-10-07 | -6.95 |
| 2024-10-04 | -6.90 |
| 2024-10-03 | -6.80 |
| 2024-10-02 | -6.82 |
| 2024-10-01 | -6.45 |
| 2024-09-30 | -6.35 |
| 2024-09-27 | -6.41 |
| 2024-09-26 | -6.18 |
| 2024-09-25 | -6.27 |
| 2024-09-24 | -6.30 |
| 2024-09-23 | -6.37 |